|
|
|
Opt-in for Free Newsletter, special discount
offers, drugs information & latest pharmacy news.
|
 |
|
Alli Receives Mixed Reviews Even After Six Months of Launch
Mon, 27 August 2007
Outlined with an aim to block the absorption of 25 percent of fat, the first FDA approved over-the-counter weight loss pill, alli still has mixed reviews to its credit. Proffered with simple dosage plan, alli was introduced into the market this year in February. A low-dose version of prescription pill orlistat, it acts by blocking action of enzymes which play a pivotal role in the digestion of body fat. Undigested fat then gets passed through bowel habits.
So, the more fat one eats, the higher fat elimination rate is. Contemplating this crucial point, the drug’s label warns of possible side effects such as oily discharge, bowel movements and diarrhea.
And when it comes to reviews, the cyberspace is filled with mixed reactions pertaining to alli’s efficacy. There is an apparent gamut of love-hate reactions on the internet. While on the Amazon website, one user opined that the side effects of the drug are remarkably unpleasant, Cecily French who tried a number of weight loss alternatives, including grapefruit, cereal, and Atkins diet, commended the drug at large, on the other. She commenced use of Alli a few months ago and lost 20 pounds of weight in just three months.
"Alli boosted my motivation to lose weight by providing a pertinent diet plan and online support network", Cecily said.
“50 percent of all users complained of fecal rush while the clinical trials, but only 5 percent of them relinquished the drug’s use on this basis” said, Vidhu Bansal, director of medical affairs for GlaxoSmithKline, manufacturers of Alli.
|